HDFC Pharma and Healthcare IDCW-R

Empty

1–7 yearsInvestment Horizon

HNI,MATarget Segments

Empty

Performance and Risk Analysis

Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.

Risk Profile

Standard Deviation15.4%

Sharpe Ratio1.25

Beta1.01

Strategy Details

A closer look at the investment thesis, portfolio construction, and current holdings.

Portfolio Holdings Overview

SectoralAllocation

Capital Goods2.24%

Services97.76%

Geographic Allocation

Domestic100%

Top Stock Holdings

CompanySectorAllocation

Divi's Laboratories LtdServices9.39%

Sun Pharmaceuticals Industries LtdServices8.28%

Treps - Tri-Party RepoUtilities4.67%

Alkem Laboratories LtdServices4.64%

Cipla LtdServices4.15%

Apollo Hospitals Enterprise LtdServices3.69%

Torrent Pharmaceuticals LtdServices3.65%

Max Healthcare Institute Ltd Ordinary SharesServices3.61%

Aster DM Quality Care Ltd Ordinary SharesServices3.56%

Lupin LtdServices3.55%

Fund House Management

The asset management company’s track record, AUM scale, and fund manager credentials.

Fund Manager Track Record

Dhruv Muchhal

Mr. Dhruv Muchhal has experience of 14 years. Manages 328 funds at HDFC Asset Management Co Ltd with an AUM of approximately ₹4,43,585 Cr Holds a B.Com degree.

26 years

Combined Team Experience

₹ 4,43,585 Cr

Assets Under Management

Operational & Regulatory Details

What it costs to invest, transaction mechanics, and regulatory disclosures you should know.

Costs and Fees

Total Expense Ratio (TER)2.16%

Regulatory & Tax Information

INF179KC1HN3

ISIN

DailyDealing Frequency

BSE Healthcare PR INRBenchmark

LTCG | >1Year 12.5%% on gain above 1.25 Lakh

STCG | <1Year 20%%

Tax Implications (India)